LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,730 | +591.7% | 100,200 | +610.6% | 0.01% | +1000.0% |
| Q2 2023 | $973 | -51.1% | 14,100 | -65.9% | 0.00% | -66.7% |
| Q1 2023 | $1,991 | +29.0% | 41,300 | +33.7% | 0.00% | +50.0% |
| Q4 2022 | $1,543 | -99.9% | 30,900 | -56.0% | 0.00% | -50.0% |
| Q3 2022 | $2,864,000 | -56.5% | 70,200 | -61.2% | 0.00% | -50.0% |
| Q1 2022 | $6,581,000 | +163.7% | 181,100 | +197.9% | 0.01% | +166.7% |
| Q2 2021 | $2,496,000 | – | 60,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |